SKI Market

Indian Indices

Sensex

84,180.96 -780.18
( -0.92%)

Global Indices

Nasdaq

49,008.56 -474.53
(-0.96%)

Dow Jones

6,942.66 -23.16
(-0.33%)

Hang Seng

51,148.76 -813.22
(-1.57%)

Nikkei 225

10,051.56 3.35
(0.03%)

Forex

USD-INR

90.15 -0.06
(-0.07%)

EUR-INR

105.56 0.04
(0.04%)

GBP-INR

121.94 0.39
(0.32%)

JPY-INR

0.58 0.00
(0.08%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

16.5329749

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

150.31

33.55

EPS(TTM)

Face Value()

Div & Yield %

0.16

Back

jtl defenc ltd

Ksolves India Ltd - Board Meeting Outcome for Approval Of Un-Audited Financial Results For The Quarter And Half Year Ended September 30 2025 And Declaration Of 2Nd Interim Dividend For FY 2025-26.

Oct 15,2025

Dear Sir/Madam Please find attached herewith the outcome of board meeting. Thanks and Regards Manisha Kide Company Secretary and Compliance Officer

84,180.96 -780.18 ( -0.92%)

49,008.56 -474.53 (-0.96%)

6,942.66 -23.16 (-0.33%)

51,148.76 -813.22 (-1.57%)

10,051.56 3.35 (0.03%)

90.15 -0.06 (-0.07%)

105.56 0.04 (0.04%)

121.94 0.39 (0.32%)

0.58 0.00 (0.08%)